blay

adj.

寒冷的；阴冷的；荒凉的；凄凉的

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial *
KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
Debiec-Rychter, M. et al. KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours...
Debiec-Rychter M, Sciot R, Le Cesne A, Schlemmer M, Hohenberger P, van Oosterom AT et al.KIT mutations and dose selection for imatin...
Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage c...
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an ...
NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)–update of the NCCN clinical practice guid...
Imatinib mesylate (STI-571 Glivec®, Gleevec™) is an active agent for gastrointestinal stromal tumours, but does not yield response...
Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing ...